Status:
ENROLLING_BY_INVITATION
Mayo Clinic IBD Biobank
Lead Sponsor:
Mayo Clinic
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18-85 years
Brief Summary
Researchers are collecting and storing blood, stool, and urine samples and medical information to better understand Inflammatory Bowel Disease (IBD) to improve disease outcome.
Detailed Description
Subjects will be sent a letter detailing the proposed biobank and soliciting enrollment. Following the informed consent process, subjects will provide a blood sample (50 ml), urine sample (50 ml), and...
Eligibility Criteria
Inclusion
- Patients diagnosed with inflammatory bowel disease (IBD) who are between the ages of 18 and 85 at time of study enrollment.
- The diagnosis of IBD will be based on the standard IBD criteria including biochemical and colonoscopy screening.
- Women with inflammatory bowel disease of childbearing potential and pregnant women will be offered enrollment because there is no risk to an unborn child in this investigation.
- Patients between the ages of 18 and 85 without history of IBD or colon cancer.
Exclusion
- Patients with known liver disease.
- Patients unable to provide informed consent.
- Prisoners and institutionalized individuals.
- Patients with a history of colorectal cancer.
Key Trial Info
Start Date :
November 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2065
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03756649
Start Date
November 1 2018
End Date
December 1 2065
Last Update
February 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905